Adhera Therapeutics Inc (ATRX) financial statements (2020 and earlier)

Company profile

Business Address 4721 EMPEROR BOULEVARD
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3400121
Cash and cash equivalents3400121
Receivables00   10
Inventory, net of allowances, customer advances and progress billings00    
Inventory00     
Prepaid expense 0  0  
Other current assets    0  
Other undisclosed current assets0000 00
Total current assets:4500131
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment00     
Intangible assets, net (including goodwill)0066777
Goodwill  44   
Intangible assets, net (excluding goodwill)0032777
Other noncurrent assets    0  
Total noncurrent assets:1066777
TOTAL ASSETS:4566898
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4222223
Accounts payable1011112
Accrued liabilities1111110
Employee-related liabilities    002
Taxes payable     0 
Interest and dividends payable21     
Debt0 00  2
Due to related parties0010   
Other undisclosed current liabilities5 20 (0)1
Total current liabilities:9263226
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt    222
Deferred tax liabilities, net   222
Other undisclosed noncurrent liabilities    396
Total noncurrent liabilities:0   5129
Total liabilities:1026371415
Stockholders' equity
Stockholders' equity attributable to parent, including:(5)3030(4)(7)
Common stock0001   
Additional paid in capital292985335333 
Accumulated deficit(35)(26)(8)(2)(334)(338)(331)
Other undisclosed stockholders' equity attributable to parent 0  00324
Total stockholders' equity:(5)3030(4)(7)
TOTAL LIABILITIES AND EQUITY:4566898

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues00  112
Revenue, net  112
Cost of revenue
(Cost of Goods and Services Sold)
(1)(0)     
Gross profit:(1)(0)  112
Operating expenses(10)(15)(6)(1)(5)(4)(2)
Operating loss:(11)(16)(6)(1)(4)(4)(0)
Nonoperating income (expense)0(1)(0)(0)7(3)(1)
Interest and debt expense(0)(1)(0)(0) 0(2)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)      
Income (loss) from continuing operations before equity method investments, income taxes:(11)(18)(6)(1)3(6)(4)
Other undisclosed income (loss) from continuing operations before income taxes(0)100 (0)2
Income (loss) from continuing operations before income taxes:(11)(17)(6)(1)3(6)(2)
Income tax expense (benefit)  (0)(0)  0
Net income (loss) attributable to parent:(11)(17)(6)(1)3(6)(2)
Preferred stock dividends and other adjustments(1)(1)     
Other undisclosed net loss available to common stockholders, basic(1)   (1)  
Net income (loss) available to common stockholders, diluted:(13)(18)(6)(1)3(6)(2)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(11)(17)(6)(1)3(6)(2)
Comprehensive income (loss), net of tax, attributable to parent:(11)(17)(6)(1)3(6)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: